Abstract

Interpretation of the clinical significance of genomic alterations remains the most severe bottleneck preventing the realization of personalized medicine in cancer. We propose a knowledge commons to facilitate collaborative contributions and open discussion of clinical decision-making based on genomic events in cancer.

Original languageEnglish
Article number438
JournalGenome biology
Volume15
Issue number8
DOIs
StatePublished - Aug 27 2014

Fingerprint

Dive into the research topics of 'Organizing knowledge to enable personalization of medicine in cancer'. Together they form a unique fingerprint.

Cite this